But the newest anti-obesity medications, are still making waves more than a year after their approval by the U.S
#GLP1 #ClinicalTrials #PatientSafety #DataIntegrity #DuplicateSubjects #ObesityResearch #VerifiedClinicalTrials #ClinicalResearch #ProtocolViolations #TrialSuccess To view or add a comment, sign in Professional patients can threaten the integrity of GLP-1 clinical trials
For example, current Wegovy injection labeling uses a staged escalation schedule that extends beyond 12 weeks before the standard maintenance stage
Symptoms like lightheadedness, dizziness, blurred vision, and unsteadiness should be taken seriously
Here are the most common scenarios people face when combining HRT and GLP-1 medications, along with guidance for each
The GI side effects, nausea, vomiting, diarrhea, are primarily peripheral effects related to GLP-1 receptor activation in the gut